Showing results (21-30 of 112) with videos related to
Sort By:
Pageof 12
Advances in Cyclic Nucleotide and Protein Phosphorylation Research|January 1, 1984
Vascular reactivity and calcium-entry blockersJ M Van Nueten, F De ClerckBiochemical Pharmacology|March 1, 1983
Platelet-mediated vascular contractions. Inhibition by flunarizine, a calcium-entry blockerF De Clerck, J M Van NuetenJournal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|December 1, 1990
Amplification mechanisms in platelet activation and arterial thrombosisF F De Clerck, P A JanssenArchives Internationales De Pharmacodynamie Et De Therapie|July 1, 1982
Haemorheological effects of ketanserin, a selective 5-HT2 receptor antagonist, in aged, spontaneously hypertensive dogsF De Clerck, A Jageneau, J DomFederation Proceedings|February 1, 1983
5-hydroxytryptamine and platelet aggregationF F De Clerck, A G HermanCardiovascular Research|May 4, 2001
Phase 2 prolongation, in the absence of instability and triangulation, antagonizes class III proarrhythmiaL M Hondeghem, K Dujardin, F De ClerckAgents and Actions|December 1, 1984
Platelet-vessel wall interactions in hemostasis: implication of 5-hydroxytryptamineF De Clerck, Y Somers, L Van GorpEuropean Journal of Pharmacology|March 18, 1983
Demonstration of S2-receptor binding sites on cat blood platelets using [3H]ketanserinJ E Leysen, W Gommeren, F De ClerckArchives Internationales De Pharmacodynamie Et De Therapie|February 1, 1978
Effect of lorcainide, a new antiarrhythmic compound, on the changes in heart rhythm induced by intravenous injection of adenosine-5'-diphosphate in ratsF De Clerck, L Van Gorp, R XhonneuxAgents and Actions|May 1, 1981
Oxatomide protects against degranulation of rat peritoneal mast cells during in vitro challenge with antigen or compound 48/80. Ultrastructural aspectsJ Van Reempts, F De Clerck, M BorgersPageof 12